BW 1592 | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

BW 1592
Annual Reports

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-1-m-2026-01-12

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

Contact Supplier

Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

Contact Supplier

pharmacompass-2-2026-02-09

BW 1592

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 17 USDMF, 2 JDMF, 12 EU WC, 6 KDMF, 16 NDC API, 16 Listed Suppliers, $ API Reference Price

39 API Suppliers
17 USDMF
2 JDMF
12 EU WC
6 KDMF
16 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

71 Drugs in Development

71 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

328 FDF Dossiers, 58 FDA Orange Book, 163 Europe, 22 Canada, 19 Australia, 53 South Africa, 13 Listed Dossiers

328 FDF Dossiers
58 FDA Orange Book
163 Europe
22 Canada
19 Australia
53 South Africa
13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG, TABLET;ORAL - 150MG;150MG;200MG;300MG, TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE, TABLET;ORAL - 120MG;EQ 15MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE, TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE, TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE, TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE, CAPSULE;ORAL - 200MG, TABLET;ORAL - 100MG;150MG, TABLET;ORAL - 133MG;200MG, TABLET;ORAL - 167MG;250MG, TABLET;ORAL - 200MG;300MG

TABLET;ORAL - 200MG;EQ 25MG BASE;300MG
TABLET;ORAL - 150MG;150MG;200MG;300MG
TABLET;ORAL - 150MG;150MG;200MG;EQ 10MG BASE
TABLET;ORAL - 120MG;EQ 15MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE
TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE
TABLET;ORAL - EQ 30MG BASE;120MG;EQ 15MG BASE
TABLET;ORAL - EQ 50MG BASE;200MG;EQ 25MG BASE
CAPSULE;ORAL - 200MG
TABLET;ORAL - 100MG;150MG
TABLET;ORAL - 133MG;200MG
TABLET;ORAL - 167MG;250MG
TABLET;ORAL - 200MG;300MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 SPI Pharma, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 4 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 26 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 8 Gangwal Chemicals, 1 Gloria Interchem, 5 Ideal Cures, 3 Ingredion Pharma Solutions, 21 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 16 Roquette, 9 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

50 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 27 Controlled & Modified Release, 25 Granulation, 22 Direct Compression, 20 Thickeners and Stabilizers, 19 Disintegrants & Superdisintegrants, 17 Solubilizers, 17 Topical, 15 Lubricants & Glidants, 11 Taste Masking, 11 Parenteral, 11 Film Formers & Plasticizers, 10 Co-Processed Excipients, 9 Empty Capsules, 8 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 3 Rheology Modifiers, 2 Coloring Agents

50 Fillers, Diluents & Binders
46 Coating Systems & Additives
27 Controlled & Modified Release
25 Granulation
22 Direct Compression
20 Thickeners and Stabilizers
19 Disintegrants & Superdisintegrants
17 Solubilizers
17 Topical
15 Lubricants & Glidants
11 Taste Masking
11 Parenteral
11 Film Formers & Plasticizers
10 Co-Processed Excipients
9 Empty Capsules
8 Chewable & Orodispersible Aids
6 Emulsifying Agents
5 API Stability Enhancers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
3 Rheology Modifiers
2 Coloring Agents

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 198 News #PharmaBuzz

4 Data Compilation #PharmaFlow
2 Stock Recap #PipelineProspector
198 News #PharmaBuzz

GLOBAL SALES INFORMATION

24 US Medicaid Prescriptions, 6 Regulatory FDF Prices, 120 Annual Reports

24 US Medicaid Prescriptions
6 Regulatory FDF Prices
120 Annual Reports

MARKET PLACE

8 APIs, 9 FDF Dossiers

8 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

80 US Patents, 10 US Exclusivities, 54 Health Canada Patents

80 US Patents
10 US Exclusivities
54 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 6 Others

4 USP
6 Others

$ API Ref.Price (USD/KG) : 318 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

120 All

01 5Atripla

02 12Biktarvy

03 1Complera

04 1Complera /Eviplera

05 8Complera/Eviplera

06 14Descovy

07 20Genvoya

08 14Odefsey

09 5Prezista/Prezcobix/Rezolsta/Symtuza

10 7Revenue share - Symtuza

11 15Stribild

12 9Symtuza

13 9Truvada

List of Suppliers

Product Main Page

01

Brand Name : Odefsey

Bictegravir, Emtricitabine, Tenofovir Alafenamide

ASCO GU

Not Confirmed

Brand Name : Odefsey

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,672

2019 Revenue in Millions : 1,655

Growth (%) : 1

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Stribild

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

ASCO GU

Not Confirmed

Brand Name : Stribild

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 196

2019 Revenue in Millions : 369

Growth (%) : -47

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Symtuza

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

ASCO GU

Not Confirmed

Brand Name : Symtuza

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 488

2019 Revenue in Millions : 379

Growth (%) : 29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Genvoya

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

ASCO GU

Not Confirmed

Brand Name : Genvoya

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 3,338

2019 Revenue in Millions : 3,931

Growth (%) : -15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Truvada

ASCO GU

Not Confirmed

Brand Name : Truvada

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,448

2019 Revenue in Millions : 2,813

Growth (%) : -49

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Descovy

Bictegravir, Emtricitabine, Tenofovir Alafenamide

ASCO GU

Not Confirmed

Brand Name : Descovy

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 1,861

2019 Revenue in Millions : 1,500

Growth (%) : 24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Symtuza

Bictegravir, Emtricitabine, Tenofovir Alafenamide

ASCO GU

Not Confirmed

Brand Name : Symtuza

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 488

2019 Revenue in Millions : 379

Growth (%) : 29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Genvoya

Bictegravir, Emtricitabine, Tenofovir Alafenamide

ASCO GU

Not Confirmed

Brand Name : Genvoya

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bictegravir, Emtricitabine, Tenofovir Alafenamide

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 3,338

2019 Revenue in Millions : 3,931

Growth (%) : -15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Biktarvy

ASCO GU

Not Confirmed

Brand Name : Biktarvy

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 7,259

2019 Revenue in Millions : 4,738

Growth (%) : 53

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Complera/Eviplera

ASCO GU

Not Confirmed

Brand Name : Complera/Eviplera

ASCO GU

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Emtricitabine

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 269

2019 Revenue in Millions : 406

Growth (%) : -34

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.